Average Co-Inventor Count = 4.65
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mitsubishi Tanabe Pharma Corporation (4 from 257 patents)
2. Forum Pharmaceuticals, Inc. (3 from 9 patents)
3. Newamsterdam Pharma B.v. (2 from 4 patents)
4. Envivo Pharmaceuticals, Inc. (1 from 13 patents)
10 patents:
1. 12378221 - Salts of obicetrapib and processes for their manufacture and intermediates thereof
2. 12006305 - Salts of obicetrapib and processes for their manufacture and intermediates thereof
3. 9550767 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
4. 9273044 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
5. 9108961 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride
6. 8754221 - Optically active cyclic alcohol compound and method for preparing the same
7. 8710227 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
8. 8471028 - Optically active cyclic alcohol compound
9. 7989627 - Optically active cyclic alcohol compound and method for preparing the same
10. 7972836 - Method of enzymatic optical resolution of racemic 4-hydroxy-1,2,3,4-tetrahydroquinoline